Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza
Clinical trial NCT02287467 · COMPLETED
Trial details
- NCT number
- NCT02287467
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2018-06-07
- Enrollment
- 329
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.